|
Volumn 59, Issue 9, 2005, Pages 997-999
|
Duodenal ulcer and gastric cancer; rare association or an indication for a change of policy?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HISTAMINE H2 RECEPTOR ANTAGONIST;
PROTON PUMP INHIBITOR;
CANCER INCIDENCE;
CLINICAL PROTOCOL;
DISEASE ASSOCIATION;
DISEASE COURSE;
DUODENUM ULCER;
EDITORIAL;
ERADICATION THERAPY;
FOLLOW UP;
GASTROSCOPY;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HIGH RISK PATIENT;
HUMAN;
INFLAMMATION;
INTESTINE METAPLASIA;
NONHUMAN;
PATHOGENESIS;
PREVALENCE;
PRIORITY JOURNAL;
STOMACH CANCER;
SYMPTOM;
BREATH ANALYSIS;
MICROBIOLOGY;
STOMACH TUMOR;
BREATH TESTS;
DUODENAL ULCER;
FOLLOW-UP STUDIES;
GASTROSCOPY;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
STOMACH NEOPLASMS;
|
EID: 33644834575
PISSN: 13685031
EISSN: 17421241
Source Type: Journal
DOI: 10.1111/j.1368-5031.2005.00654b.x Document Type: Editorial |
Times cited : (1)
|
References (5)
|